BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36273983)

  • 21. Measurement of the levels of reticulated platelets after plateletpheresis to monitor activity of thrombopoiesis.
    Stohlawetz P; Stiegler G; Jilma B; Dettke M; Höcker P; Panzer S
    Transfusion; 1998 May; 38(5):454-8. PubMed ID: 9633558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of plateletpheresis on the Fenwal CS-3000 on donor platelet counts.
    Kalish RI; Chambers LA; Linden JV
    J Clin Apher; 1987; 3(4):230-4. PubMed ID: 3680195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of double dose plateletpheresis on target yield and donor platelet recovery.
    Chopra S; Kaur P; Bedi RK; Kaur G
    Hematol Transfus Cell Ther; 2023; 45(1):16-24. PubMed ID: 34294601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of random-donor platelet concentrates prepared from whole blood units and platelets prepared from single-donor apheresis collections.
    Sloand EM; Yu M; Klein HG
    Transfusion; 1996; 36(11-12):955-9. PubMed ID: 8937403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD4+ T-cell lymphopenia in frequent platelet donors who have ceased platelet donation for at least 1 year.
    Rahmani M; Fortin BM; Berliner N; Issa N; Neuberg D; Kaufman RM; Gansner JM
    Transfusion; 2019 May; 59(5):1644-1647. PubMed ID: 30747442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent plateletpheresis does not clinically significantly decrease platelet counts in donors.
    Katz L; Palmer K; McDonnell E; Kabat A
    Transfusion; 2007 Sep; 47(9):1601-6. PubMed ID: 17725723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin.
    Goodnough LT; Kuter DJ; McCullough J; Slichter SJ; DiPersio J; Romo J; Peterson R; Smith KJ; Raife T; Tomita D; Armstrong S
    Blood; 2001 Sep; 98(5):1346-51. PubMed ID: 11520781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increase in endogenous thrombopoietin in healthy donors after automated plateletpheresis.
    Dettke M; Hlousek M; Kurz M; Leitner G; Rosskopf K; Stiegler G; Stohlawetz P; Worel N; Höcker P; Panzer S
    Transfusion; 1998 May; 38(5):449-53. PubMed ID: 9633557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A statistical model for estimating donor postdonation platelet counts after plateletpheresis.
    Cabezudo I; Winegarden DK; Randels MJ; Strauss RG
    Transfusion; 1994 Jan; 34(1):54-7. PubMed ID: 8273130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Donor platelet response and product quality assurance in plateletpheresis.
    Lasky LC; Lin A; Kahn RA; McCullough J
    Transfusion; 1981; 21(3):247-60. PubMed ID: 7233509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Giant Platelets in Platelet Donors - A Blessing in Disguise?
    Roy AD; Choudhury N; Ray D
    J Clin Diagn Res; 2015 Jun; 9(6):EC01-3. PubMed ID: 26266124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination
    Thuku NW; Shikuku K; Mbugua A
    Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of plateletpheresis on postdonation serum thrombopoietin levels and its correlation with platelet counts in healthy voluntary donors.
    Hans R; Sharma RR; Marwaha N
    Asian J Transfus Sci; 2019; 13(1):10-16. PubMed ID: 31360004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the use of a platelet-counting tool in plateletpheresis.
    Ho TF; Yang BS; Huang YT; Hung CT
    Vox Sang; 1999; 76(4):226-30. PubMed ID: 10394142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plateletpheresis in 90- to 110-pound donors using the CS-3000 blood cell separator.
    Buchholz DH; Squires JE; Herman JH; Ng AT; Anderson JK; Hedberg SL
    Transfusion; 1997 Jul; 37(7):715-8. PubMed ID: 9225935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequent platelet donation is associated with lymphopenia and risk of infections: A nationwide cohort study.
    Zhao J; Gabriel E; Norda R; Höglund P; Baden L; Diedrich BA; Marits P; Enoksson SL; Gansner JM; Kaufman R; Dickman PW; Edgren G
    Transfusion; 2021 Feb; 61(2):464-473. PubMed ID: 33186486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reference interval of platelet counts and other platelet indices in apparently healthy blood donors in North India according to Clinical and Laboratory Standards Institute guidelines: Need to redefine the platelet count cutoffs for repeat plateletpheresis donation?
    Pabbi S; Tiwari AK; Aggarwal G; Sharma G; Marik A; Luthra AS; Upadhyay AP; Singh MK
    Asian J Transfus Sci; 2022; 16(2):245-250. PubMed ID: 36687539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of historical platelet counts from blood donors to program apheresis platelet donation: An Australian perspective.
    Hirani R; Peberdy J; Mondy P
    Transfus Apher Sci; 2018 Apr; 57(2):239-242. PubMed ID: 29530405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequent plateletpheresis donations & its effect on haematological parameters: An observational study.
    Nayak S; Coshic P; Pandey RM; Chatterjee K
    Indian J Med Res; 2019 Nov; 150(5):468-476. PubMed ID: 31939390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The apheresis platelet donation was increased after a nationwide ban on family/replacement donation in China.
    Chen J; Zhou G; Fu X; Li S; Li Y; Kang J; Chen H; Zhou L; Fu Y
    BMC Public Health; 2021 Apr; 21(1):819. PubMed ID: 33926409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.